PAMORELIN LA 11.25 INJ.

About

Pamorelin LA 11.25 Injection contains triptorelin, a synthetic analogue of gonadotropin-releasing hormone (GnRH). This long-acting formulation is designed to provide sustained suppression of sex hormone production by downregulating GnRH receptors in the pituitary gland. Following an initial transient surge, continuous administration leads to a profound and sustained decrease in the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This ultimately results in a significant reduction of testosterone levels in men and estrogen levels in women, effectively achieving medical castration. The 11.25 mg dose is typically administered every three months, offering a highly convenient and extended treatment interval for chronic hormone-dependent conditions. This prolonged action helps to maintain consistent therapeutic hormone suppression, which is critical for managing conditions like advanced prostate cancer, where continuous androgen deprivation is essential for disease control.

Uses

• Treatment of advanced prostate cancer.
• Management of endometriosis.
• Treatment of uterine fibroids.
• Management of central precocious puberty.

Directions For Use

Administer as a single intramuscular injection, typically once every three months, as directed by a healthcare professional. Ensure proper reconstitution before use.

Benefits

• Provides prolonged and sustained hormonal suppression.
• Highly convenient dosing schedule (quarterly).
• Effective in reducing tumor growth in hormone-sensitive cancers.
• Alleviates symptoms of endometriosis and fibroids.
• Helps manage central precocious puberty.
• Improves patient adherence to long-term therapy.

Side Effects

• Hot flashes
• Sweating
• Fatigue
• Headache
• Injection site reactions
• Bone pain
• Muscle weakness
• Mood changes
• Decreased libido
• Nausea
• Vomiting
• Weight gain

Safety Measures

• Alcohol - Alcohol consumption may exacerbate hot flashes and other side effects; use with caution.
• Pregnancy - Contraindicated in pregnancy due to its hormonal effects and potential harm to the fetus.
• Breastfeeding - Not recommended during breastfeeding as it may affect hormone levels and pass into breast milk.
• Liver - Use with caution in patients with severe liver impairment; monitoring may be required.
• Kidney - Generally no dose adjustment needed for kidney impairment, but caution is advised in severe cases.
• Lung - No specific precautions for lung conditions are typically required.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.